We are live on
!
Find out more
CRIG
Charter Research & Investment Group Portfolio holdings
AUM
$150M
1-Year Est. Return
28.05%
This Fund
S&P 500
This Quarter
Est. Return
+10.7%
1 Year Est. Return
+28.05%
3 Year Est. Return
+71.14%
5 Year Est. Return
+100.32%
10 Year Est. Return
–
AUM
$144M
AUM Growth
+$10.5M
(+7.8%)
Cap. Flow
-$1.46M
Cap. Flow
% of AUM
-1.01%
Top 10 Holdings %
Top 10 Hldgs %
46.1%
Holding
85
New
2
Increased
13
Reduced
29
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$238K |
| 2 |
Corning
GLW
|
+$232K |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$142K |
| 4 |
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$112K |
| 5 |
Costco
COST
|
+$95.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$607K |
| 2 |
Apple
AAPL
|
+$222K |
| 3 |
Hubbell
HUBB
|
+$208K |
| 4 |
Texas Instruments
TXN
|
+$203K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$151K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Communication Services | 16.49% |
| 3 | Consumer Staples | 11.03% |
| 4 | Healthcare | 10.02% |
| 5 | Industrials | 7.94% |
Similar funds
RPA
RB
PAYA
JIM
FC
PCMNC
GWA
TWM
Charter Research & Investment Group's Q3 2025 Portfolio in Review
As of Q3 2025, Charter Research & Investment Group held 85 positions worth $144M, up 7.8% from $134M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.7%. Charter Research & Investment Group opened 2 new positions and exited 2, leaving the 85-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Communication Services and Consumer Staples.
- Charter Research & Investment Group's largest Q3 2025 buy was Alnylam Pharmaceuticals: 585 shares worth $267K.
- Charter Research & Investment Group added most to Invesco S&P 500 Equal Weight ETF in Q3 2025, an estimated $142K increase.
- Charter Research & Investment Group's biggest Q3 2025 reduction was Merck, cutting an estimated $607K.
- Charter Research & Investment Group fully exited Hubbell in Q3 2025, selling an estimated $208K.
- Charter Research & Investment Group's ten largest holdings make up 46% of its $144M portfolio in Q3 2025.
- Charter Research & Investment Group opened 2 new positions and closed 2 in Q3 2025.
- Charter Research & Investment Group's portfolio value rose 7.8% quarter-over-quarter to $144M.
Based on Charter Research & Investment Group's 13F filing for Q3 2025, filed 12 Nov 2025.